Actavis to Buy Forest Labs

Actavis to Buy Forest Labs. Generic drug maker Actavis PLC (ACT) will buy Forest Labs (FRX) for approximately $25 billion in cash and stock. Actavis will pay $89.48 per share, representing a premium of 25% to Forest's closing price on Friday. The offer comprises $26.04 in cash and 0.3306 Actavis share for every Forest share. Actavis said the deal should increase its profits by double-digit percentages in 2015 and 2016, including about $1 billion in tax and operating savings.

Upgrades:

Abbott (ABT): ResearchTeam raised their rating from Reduce to Hold.

Allstate (ALL): ResearchTeam raised their rating from Reduce to Hold.

Berkshire Hathaway (BRK.B): First Call raised their rating from Buy to Strong Buy.

Blackberry (BBRY): FBR Capital raised their rating from Underperform to Market Perform and raised their target price from $6.75 to $10.00. Pre-market: 9.38 +0.40 (4.45%)

Express Scripts (ESRX): Monness Crespi raised their rating from Neutral to Buy. Pre-market: 76.99 +0.24 (0.31%)

GlaxoSmithKline (GSK): ResearchTeam raised their rating from Reduce to Hold.

Intuitive Surgical (ISRG): First Call raised their rating from Hold to Buy.

J.M. Smucker Co. (SJM): Stephens raised their rating from Equal Weight to Overweight and raised their target price from $110.00 to $115.00. Pre-market: 92.07 +0.26 (0.28%)

Kraft (KRFT): ResearchTeam raised their rating from Reduce to Hold.

Mosaic (MOS): ResearchTeam raised their rating from Reduce to Hold.

Praxair (PX): ResearchTeam raised their rating from Reduce to Hold.

Total SA (TOT): ResearchTeam raised their rating from Reduce to Hold.

Waste Management (WM): ResearchTeam raised their rating from Reduce to Hold. Pre-market: 42.40 -1.27 (-2.91%)

Downgrades:

Hormel (HRL): ResearchTeam lowered their rating from Hold to Reduce.

Intel (INTC): ResearchTeam lowered their rating from Hold to Reduce.

Microsoft (MSFT): ResearchTeam lowered their rating from Hold to Reduce. Pre-market: 37.58 -0.04 (-0.11%)

Coverage Initiated:

Allscripts Healthcare (MDRX): Citigroup initiated coverage with a Neutral rating and target price of $18.00.

Credit Suisse (CS): Jefferies initiated coverage with a Buy rating. Pre-market: 32.07 +0.62 (1.97%)

Deutsche Bank (DB): Jefferies initiated coverage with a Buy rating. Pre-market: 49.27 +0.35 (0.72%)

UBS (UBS): Jefferies initiated coverage with a Hold rating. Pre-market: 20.97 +0.13 (0.62%)

Earning Reports:

Coca-Cola (KO): Reported EPS of $0.46 in-line with estimates. Pre-market: 38.10 -0.83 (-2.13%)

Diana Shipping (DSX): Reported EPS of -$0.12 missing estimates by -$0.06. Pre-market: 11.90 -0.79 (-6.23%)

Duke Energy (DUK): Reported EPS of $1.00 beating estimates by +$0.05. Pre-market: 71.45 0.00 (0.00%)

Genuine Parts (GPC): Reported EPS of $0.97 beating estimates by +$0.04.

Medtronic (MDT): Reported EPS of $0.91 in-line with estimates. Pre-market: 57.00 +0.12 (0.21%)

Waste Management (WM): Reported EPS of $0.56 missing estimates by -$0.04. Pre-market: 42.40 -1.27 (-2.91%)

Markets: 
Futures at 8:34: Dow +0.09%. S&P +0.03%. Nasdaq +0.09%. Crude +0.90% to $101.20. Gold -0.02% to $1318.50. U.S. 10 Year +5/32 to 2.732%.

Europe: London +0.33%. Paris -0.25%. Frankfurt -0.06%. 

Asia: Japan +3.13% to 14843. Hong Kong +0.23% to 22588. China -0.77% to 2119. India +0.83% to 20634. 

#TopWealthManager #RLPaler #WallStreet #PreMarket #WealthManagement #FinancialPlanning #AnalystsRatings #EarningReports